Thank You

We have received your message.

Read in our articles

Biosimilars Registration: SFDA Considerations

By Regulatory Editor|16/03/2025|Pharmaceuticals, Regulatory Affairs|

Literature Monitoring Activity in Saudi PV Systems

By Sara Alakeel|03/03/2025|Pharmacovigilance|

Veterinary Drug Registration in SFDA

By Abeer Mazyad|08/02/2025|Regulatory Affairs, Veterinary|

How to write Economic Evaluation Studies (EES) for SFDA?

By Madiha Baaj|14/01/2025|Pharmaceuticals, Regulatory Affairs|

SaMD Registration in SFDA (Software as a Medical Device)

By Yumna Siraj|07/12/2024|Medical Devices|

MDMA Update and Change of Information

By Mohamed Bashim|06/12/2024|Medical Devices|

Overview of SFDA Conditional Approval for New Medicines

By Madiha Baaj|02/12/2024|Pharmaceuticals, Regulatory Affairs|

SFDA Drug Pricing Rules in Saudi Arabia

By Rawd Alsubaie|30/11/2024|Pharmaceuticals, Regulatory Affairs|

CAR T Cell Registration in SFDA

By Regulatory Editor|08/07/2024|Pharmaceuticals, Regulatory Affairs|

Contact Our Business Support Team

Sunday to Thursday: 9:00 am – 5:00 pm

+966 11 277 7729

+966 11 240 4409